Thermo Fisher Scientific and Hamilton Partner to Offer Storage Solutions
|
By LabMedica International staff writers Posted on 09 Nov 2016 |

Image: The Decapper 500 and 550 systems are designed for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories (Photo courtesy of Business Wire).
Thermo Fisher Scientific Inc. (Waltham, MA, USA) and Hamilton Storage (Reno, NV, USA) have entered into a partnership to offer the fully automated Thermo Scientific Decapper 500 and 550 Series tube capping systems for researchers seeking to streamline their sample storage processes.
Biological samples are usually stored in multiple tube types, requiring users to buy multiple decappers. The new decapper system does the work of multiple systems and features Quick Switch technology that seamlessly transitions between different tube and rack types. Users can now cap and decap both Thermo Scientific Matrix and Nunc automation tubes without being required to own multiple pieces of equipment.
The Decapper 500 and 550 systems fill a gap between low-throughput, manual eight-channel handheld decappers and high throughput, entire-rack decappers for automated workstations. They are both suitable for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories doing compound storage, high-throughput screening, biobanking and genomic storage.
“To address customer demand for more flexible and functional decapping equipment, Thermo Fisher partnered with Hamilton Storage, an industry leader in cryogenic sample storage systems,” said Chris Tsourides, senior business director, Thermo Fisher Scientific. “These two new decappers show what’s possible when two industry innovators join forces. Together, we’re delivering significant time and cost savings to scientists all over the world.”
“We constantly seek new ways to streamline customer efficiencies, and with Thermo Fisher as a partner, our commitment is further strengthened,” adds Matt Hamilton, president of Hamilton Storage. “This means that our mutual customers will benefit from a robust, time-saving and integrated-friendly workflow solution.”
Related Links:
Thermo Fisher Scientific
Hamilton Storage
Biological samples are usually stored in multiple tube types, requiring users to buy multiple decappers. The new decapper system does the work of multiple systems and features Quick Switch technology that seamlessly transitions between different tube and rack types. Users can now cap and decap both Thermo Scientific Matrix and Nunc automation tubes without being required to own multiple pieces of equipment.
The Decapper 500 and 550 systems fill a gap between low-throughput, manual eight-channel handheld decappers and high throughput, entire-rack decappers for automated workstations. They are both suitable for use in medium- to high-throughput biotech, pharmaceutical and clinical laboratories doing compound storage, high-throughput screening, biobanking and genomic storage.
“To address customer demand for more flexible and functional decapping equipment, Thermo Fisher partnered with Hamilton Storage, an industry leader in cryogenic sample storage systems,” said Chris Tsourides, senior business director, Thermo Fisher Scientific. “These two new decappers show what’s possible when two industry innovators join forces. Together, we’re delivering significant time and cost savings to scientists all over the world.”
“We constantly seek new ways to streamline customer efficiencies, and with Thermo Fisher as a partner, our commitment is further strengthened,” adds Matt Hamilton, president of Hamilton Storage. “This means that our mutual customers will benefit from a robust, time-saving and integrated-friendly workflow solution.”
Related Links:
Thermo Fisher Scientific
Hamilton Storage
Latest Industry News
- QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio
- WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories
- AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
- New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
- Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
- WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
- BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
- Abbott Acquires Cancer-Screening Company Exact Sciences
- Roche and Freenome Collaborate to Develop Cancer Screening Tests
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
Channels
Clinical Chemistry
view channel
Rapid Blood Testing Method Aids Safer Decision-Making in Drug-Related Emergencies
Acute recreational drug toxicity is a frequent reason for emergency department visits, yet clinicians rarely have access to confirmatory toxicology results in real time. Instead, treatment decisions are... Read more
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read moreMolecular Diagnostics
view channel
Group A Strep Molecular Test Delivers Definitive Results at POC in 15 Minutes
Strep throat is a bacterial infection caused by Group A Streptococcus (GAS). It is a leading bacterial cause of acute pharyngitis, particularly in children and adolescents, and one of the most common reasons... Read more
Rapid Molecular Test Identifies Sepsis Patients Most Likely to Have Positive Blood Cultures
Sepsis is caused by a patient’s overwhelming immune response to an infection. If undetected or left untreated, sepsis leads to tissue damage, organ failure, permanent disability, and often death.... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria
Antibiotic resistance has accelerated into a global health crisis, with projections estimating more than 10 million deaths per year by 2050 as drug-resistant “superbugs” continue to spread.... Read more
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read morePathology
view channel
AI Tool Uses Blood Biomarkers to Predict Transplant Complications Before Symptoms Appear
Stem cell and bone marrow transplants can be lifesaving, but serious complications may arise months after patients leave the hospital. One of the most dangerous is chronic graft-versus-host disease, in... Read more
Research Consortium Harnesses AI and Spatial Biology to Advance Cancer Discovery
AI has the potential to transform cancer care, yet progress remains constrained by fragmented, inaccessible data that hinder advances in early diagnosis and precision therapy. Unlocking patterns missed... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more







